LYNDA LOMBARDI: Open Payments
NPI 1992128128 · GROTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 4 companies in 2025. Trend: 2023 $63 · 2024 $0 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Astellas Pharma US Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: QULIPTA, Veozah, Rybelsus, GEMTESA, VRAYLAR, Ozempic.
Industry payments across CT — which companies pay providers there.
